Altre lingue Helixmith Co., Ltd

Azioni

A084990

KR7084990001

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 04/07/2024			Variaz. 5gg	Var. 1 gen.
3.550 ^KRW	-1,39%		+1,57%	-42,46%

2023	Helixmith Co. Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2023	CI
2022	I titoli della Corea del Sud calano di quasi il 2% per i timori di un rialzo dei tassi negli Stati Uniti; Samsung perde il 2%	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Helixmith Co., Ltd announced that it has received KRW 3.37919826 billion in funding	25/04
Helixmith Co., Ltd announced that it expects to receive KRW 3.37919826 billion in funding	05/02
Helixmith Stock Plummets Following Clinical Setback in Gene Therapy Candidate	04/01
Helixmith Co., Ltd announced that it has received KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.	28/12
Helixmith Co., Ltd announced that it expects to receive KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.	20/12
Helixmith Co., Ltd announced that it has received KRW 19.999986156 billion in funding from CANARIABIO M Inc.	31/08/23
Helixmith Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Diabetic Foot Ulcers Pipeline Assets Segmented by Stage, Product Type, Route of Administration, and Molecule Type	14/03/23
Helixmith Co., Ltd announces tranche update	15/02/23
Helixmith Co., Ltd announced that it expects to receive KRW 19.999986156 billion in funding from CANARIABIO M Inc.	07/02/23
Helixmith Co., Ltd announced that it has received KRW 34.99999386 billion in funding from CANARIABIO M Inc.	29/12/22
Sejong Medical Co., Ltd. announced that it has received KRW 30 billion in funding from Helixmith Co., Ltd	29/12/22
South Korean Stocks Decline Nearly 2% over Rate Hike Fears in the US; Samsung Loses 2%	23/12/22
Helixmith to Raise 35 Billion Won From Stock Sale; Shares Decline 7%	23/12/22
Helixmith Co., Ltd announced that it expects to receive KRW 34.99999386 billion in funding from CANARIABIO M Inc.	21/12/22
Sejong Medical Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Helixmith Co., Ltd	21/12/22
Helixmith : to Present New ALS-Focused Development Program at Upcoming Conferences	05/10/22
Helixmith Co., Ltd(KOSDAQ:A084990) dropped from FTSE All-World Index	19/09/22
Helixmith : Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS	08/09/22
Helixmith Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS (Amyotrophic Lateral Sclerosis)	06/09/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Helixmith Co., Ltd

Azioni

A084990

KR7084990001

Altre lingue

Filtri